Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03325985 · ClinicalTrials.gov registry record · NA
Emergency Medicine Palliative Care Access
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 1,606
- Enrollment target
NCT03325985: Completed NA study, sponsored by NYU Langone Health.
NCT03325985 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 1,606 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (14% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03325985, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,606 participants
- Enrollment target
Study Summary
This is a two-arm, multi-site randomized controlled trial of 1,350 older adults (50+ years) with either advanced cancer (defined as metastatic solid tumor) or poor prognosis end-stage organ failure (New York Heart Association (NYHA) Class III or IV Congestive Heart Failure (CHF), End-Stage Renal Disease (ESRD), defined as Glomerular Filtration Rate (GFR) \< 15 ml/min/m2 or dialysis ; or Global Initiative for Chronic Obstructive Lung Disease (GOLD) Stage III or higher, or oxygen-dependent chronic obstructive pulmonary disease (COPD) who present to the Emergency Department (ED), along with 675 of their informal caregivers. Investigators will compare the effectiveness of two distinct palliative care models: a) nurse-led telephonic case management; and b) facilitated, outpatient specialty palliative care.
Primary Outcome
* Measured by change from enrollment to 6 months * Used to measure a person's quality of life * 27 questions total * 5-point Likert scale * Reverse code select items per scoring guidelines at facit.org, then calculate a summary score for each respondent. The total score ranges from 0-108 points; higher scores indicate greater quality of life.
Interventions
- BEHAVIORAL Nurse-led telephonic case management
- BEHAVIORAL Facilitated,outpatient specialty palliative care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,606 participants |
| Start Date | 2018-03-28 |
| Est. Completion | 2023-08-24 |
| Phase | NA |
What the finished NCT03325985 record still lists
NCT03325985 is an interventional study that assigns participants to a tested intervention. Its 1,606 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (14% higher).
The record links to 0 conditions, and to 2 interventions - of which Nurse-led telephonic case management is the first listed.
NCT03325985 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03325985 about?
NCT03325985 is a clinical study titled "Emergency Medicine Palliative Care Access". This is a two-arm, multi-site randomized controlled trial of 1,350 older adults (50+ years) with either advanced cancer (defined as metastatic solid tumor) or poor prognosis end-stage organ failure (New York Heart Association (NYHA) Class III or IV Congestive Heart Failure (CHF), End-Stage Renal Dis...
What is the current status of trial NCT03325985?
This trial is currently completed. It is a NA study. The enrollment target is 1,606 participants. The study started on 2018-03-28. Estimated completion is 2023-08-24.
What interventions are being tested in trial NCT03325985?
The interventions under investigation include: Nurse-led telephonic case management (BEHAVIORAL), Facilitated,outpatient specialty palliative care (BEHAVIORAL).
Who is sponsoring clinical trial NCT03325985?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03325985's enrollment target sits among peer trials
1,606 63rd of 2000 higher than 1,938 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06271590 · 1,605 participants · NA
MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels
- NCT00646022 · 1,600 participants
Natural History of Familial Carcinoid Tumor
- NCT03109197 · 1,600 participants
Sudden Unexplained Death in Childhood (SUDC) Registry
- NCT03511118 · 1,600 participants
Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI